Source: Annual Congress 2008 - Epigenetic modifications in lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. M. Adcock (London, United Kingdom). Decreased histone deacetylase activity in COPD. Annual Congress 2008 - Epigenetic modifications in lung disease

Member's Comments

No comment yet.

Related content which might interest you: Histone deacetylase activity is reduced in COPD. Modulation by theophylline Source: Eur Respir J 2003; 22: Suppl. 45, 4s Year: 2003 Histone deacetylase activity and gene expression in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 316s Year: 2001 Histone acetylation and deacetylation: importance in inflammatory lung diseases Source: Eur Respir J 2005; 25: 552-563 Year: 2005 Low-dose theophylline improves lung inflammatory profile during COPD exacerbations by increasing histone deacetylase activity Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD Year: 2008 Steroids and histone deacetylase in ventilation-induced gene transcription Source: Eur Respir J 2007; 30: 865-877 Year: 2007 The role of histone deacetylase 9 in the imbalance of Th17/Treg in bronchial asthma Source: Annual Congress 2012 - Mechanisms of asthma Year: 2012 Histone deacetylases (HDACs) and lung disease Source: Annual Congress 2011 - Why is epigenetics important for lung disease? Year: 2011 Histone deacetylases reduction causes defect of Nrf2 response, leading to a reduction of anti-oxidant capacity in COPD Source: Annual Congress 2010 - Pathology and immunology of COPD Year: 2010 Effect of cigarette smoking on histone deacetylase activity in alveolar macrophages Source: Eur Respir J 2002; 20: Suppl. 38, 416s Year: 2002 Citrullinated histone H3 is increased in blood of asthma subjects Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019 Moraxella infection and histone deacetylase activity Source: Annual Congress 2008 - Epigenetic modifications in lung disease Year: 2008 Implication of the histone methyltransferase EZH2 in pulmonary arterial hypertension Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 LSC Abstract – Histone deacetylase 7 mediated metabolic remodeling: A new crosslink between pulmonary hypertension and cancer Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Global histone H3 lysine 4 (H3K4) dimethylation is an important prognostic factor in lung cancer Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Expression of histone deacetylases (HDAC3) and phosporylated-cAMP response element-binding (P-CREB) in bronchial biopsies of asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 470s Year: 2004 microRNA-223 suppresses histone deacetylase 2 in chronic obstructive pulmonary disease Source: International Congress 2015 – Latest news on miRNAs in pulmonary research Year: 2015 Effect of cigarette smoke extract (CSE) on histone acetylation of lung fibroblasts in vitro compared to histone acetylation in patients with lung emphysema Source: Eur Respir J 2006; 28: Suppl. 50, 583s Year: 2006 The effects of dexamethasone and IL-1β on histone H3 methylation in A549 cells Source: Eur Respir J 2003; 22: Suppl. 45, 224s Year: 2003 Comparison of anticancer effects of a novel histone deacetylase (HDAC) inhibitor CG200745 and SAHA in non-small lung cancer cells Source: International Congress 2019 – Diagnostic procedures and biology of lung cancer Year: 2019